Intuitive Surgical, Inc.

Valuation Analysis

About the Company

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers,

Intuitive Surgical, Inc. Stock at a Glance

Intuitive Surgical, Inc. (ISRG) is currently trading at $411.06 with a market capitalization of $145.6B. The trailing P/E ratio stands at 50.01x, with a forward P/E of 34.88x. The 52-week range spans from $396.68 to $603.88; the current price is 31.9% below the yearly high. Year-over-year revenue growth stands at +23.0%. The net profit margin stands at 28.15%.

💰 Dividend

Intuitive Surgical, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

29 analysts rate Intuitive Surgical, Inc. (ISRG) on consensus: Buy. The average price target is $565.08, implying +37.47% from the current price. Analyst price targets range from $366.00 to $750.00.

Intuitive Surgical, Inc.: The Investment Case in Detail

Intuitive Surgical, Inc. (ISRG) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Revenue is growing at a healthy 23% pace year-over-year, suggesting the business model continues to find new customers and pricing power. With a gross margin near 66.29%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Free cash flow is positive and net margins stand at 28.15%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions.

The Bear Case

Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valuation in Context

The EV/EBITDA multiple of 36.34x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.

What to Watch Next

• The forward P/E of 34.88x is meaningfully below the trailing 50.01x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 37.47% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to market-like volatility.

Trading Data

Related Stocks in the Same Sector

Where can I buy Intuitive Surgical, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.